Showing 421 - 440 results of 122,371 for search '(( 10 ((mean decrease) OR (nn decrease)) ) OR ( 5 ((mg decrease) OR (a decrease)) ))', query time: 1.29s Refine Results
  1. 421
  2. 422
  3. 423

    LPS-induced decrease in Sp1 DNA binding activity is associated with an increased NF-κB binding activity. by Xiaobing Ye (49295)

    Published 2015
    “…<p>Wild type (WT) mice were injected with saline (1 ml/kg, Con) or <i>Samonelia Enteritidis</i> LPS (10 mg/kg, i.p.). Lung tissue level of Sp1 (A) or NF-κB (B) DNA binding activity was measured at the indicated times (in minutes) after LPS injection, using electrophoretic mobility shift assay (EMSA). …”
  4. 424
  5. 425
  6. 426
  7. 427
  8. 428
  9. 429
  10. 430
  11. 431
  12. 432
  13. 433
  14. 434

    APB5, but not APA5, decreases apoptosis in alveolar epithelial cells in lungs of BLM-treated mice. by Masami Kishi (6167105)

    Published 2018
    “…The administration of APA5 did not change the number of TUNEL-positive cells from that in BLM-treated mice, whereas that of APB5 significantly decreased them. …”
  15. 435

    Weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on pre-specified atherosclerotic traits. by Aeron M. Small (9617751)

    Published 2020
    “…<p>Odds Ratio and 95% confidence interval is displayed for the effect of a genetically determined 10 mg/dL decrease in LDL-C on primary atherosclerotic traits for White individuals, Black individuals, Hispanic individuals, and inverse variance weighted meta-analysis of White, Black, and Hispanic populations (IVWMA). …”
  16. 436
  17. 437
  18. 438

    The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of sucrose using the drinking in the dark model in mice. by Pia Steensland (362091)

    Published 2013
    “…<p>The highest dose of ezlopitant (15 mg/kg) decreased consumption of 5% sucrose (<b>A</b>). …”
  19. 439
  20. 440